Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Share-based Compensation (2024 - 2025)

Carlsmed (CARL) has disclosed Share-based Compensation for 2 consecutive years, with $790000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation rose 690.0% year-over-year to $790000.0, compared with a TTM value of $1.7 million through Dec 2025, changed N/A, and an annual FY2025 reading of $1.9 million, up 661.66% over the prior year.
  • Share-based Compensation was $790000.0 for Q4 2025 at Carlsmed, up from $704000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $790000.0 in Q4 2025 and bottomed at $66000.0 in Q3 2024.